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ABSTRACT
The heart is a mechanically-active organ that dynamically senses its own mechanical environment. This
environment is constantly changing, on a beat-by-beat basis, with additional modulation by respiratory
activity and changes in posture or physical activity, and further overlaid with more slowly occurring
physiological (e.g. pregnancy, endurance training) or pathological challenges (e.g. pressure or volume
overload). Far from being a simple pump, the heart detects changes in mechanical demand and adjusts
its performance accordingly, both via heart rate and stroke volume alteration. Many of the underlying
regulatory processes are encoded intracardially, and are thus maintained even in heart transplant
recipients. Over the last three decades, molecular substrates of cardiac mechanosensitivity have
gained increasing recognition in the scientific and clinical communities. Nonetheless, the processes
underlying this phenomenon are still poorly understood. Stretch-activated ion channels (SAC) have
been identified as one contributor to mechanosensitive autoregulation of the heartbeat. They also
appear to play important roles in the development of cardiac pathologies – most notably stretch-
induced arrhythmias. As recently discovered, some established cardiac drugs act, in part at least,
via mechanotransduction pathways suggesting SAC as potential therapeutic targets. Clearly,
identification of the molecular substrate of cardiac SAC is of clinical importance and a number of
candidate proteins have been identified. At the same time, experimental studies have revealed
variable–and at times contrasting–results regarding their function. Further complication arises from
the fact that many ion channels that are not classically defined as SAC, including voltage and ligand-
gated ion channels, can respond to mechanical stimulation. Here, we summarise what is known about
the molecular substrate of the main candidates for cardiac SAC, before identifying potential further
developments in this area of translational research.
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INTRODUCTION
Mechanosensitivity is an intrinsic property of cardiac functional autoregulation (Figure 1), affecting
mechanical activity (e.g. via the Frank-Starling effect1,2: an acute stretch-induced increase in cardiac
contractility in the absence of raised intracellular calcium) and electrical behaviour (e.g. through the
Bainbridge effect3: the stretch-induced increase in spontaneous pacemaker rate) of the heart.
These mechano-electric feedback (MEF) responses are sustained in denervated (e.g. isolated4–6 or
transplanted7–9) hearts, in isolated tissue10,11 and even single cells – in both cardiac myocytes12–16
and non-myocytes.17–19
Adaptation to a highly dynamic mechanical environment is a crucial feature of normal cardiac
function. It is involved in the regulation of beat-by-beat physiology,4,20,21 and implicated in the
progression of cardiac diseases, including rhythm disturbances.22–25 For a compendium of current
insight into cardiac mechano-electric coupling and arrhythmias, from pipette to patient, see26.
Although the mechanisms underlying cardiac mechanotransduction are not completely understood,
key players are thought to include mechanosensitive ion channels (MSC). MSC are defined in the
broadest sense by their ability to change ion channel open probability in response to mechanical
stimuli, thereby converting mechanical energy into the modification of an electrochemical signal.27
MSC have been demonstrated to act as functional mechanotransducers in a number of different
tissues, including the heart, and their block is capable of preventing or terminating certain
mechanically-induced arrhythmias.28,29
MSC can be subcategorised by the type of mechanical stimulation required for channel
activation. Although these boundaries are far from clear-cut, it is useful to make this conceptual
distinction. In this review we shall focus on stretch-activated ion channels (SAC), which are those MSC
whose switching from ‘closed’ to ‘open’ state can be driven over their full dynamic range by stretch
alone, for example through direct mechanical membrane deformation (Figure 2).
Another subcategory of MSC, cell volume-activated ion channels (VAC), are also considered to
respond to mechanical stimuli,30 but these differ in their micro-mechanical deformation properties (cell
swelling increases cell diameter with less dominant effects on length, while axial stretch increases cell
Figure 1. Simplified diagram of cardiac electromechanical integration. Cardiac electrophysiology controls cardiac
mechanics via excitation-contraction coupling. Changes in the heart’s mechanical environment from contraction
or external interventions affect electrophysiology via mechano-electric feedback. This intra-cardiac regulatory
loop (middle) is subject to modulation by extra-cardiac control (top) and environmental parameters (bottom).
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length and reduces diameter), time course of response (VAC usually show a lag-time of tens of seconds
to minutes between the onset of cell swelling and channel opening, while SAC activate
instantaneously), and pathophysiological context (it is assumed that – in contrast to ischaemia or
hypertrophy – the normal cycle of contraction and relaxation is not associated with cell volume
changes). For these reasons, VAC are unlikely to be main contributors to acute and/or beat-by-beat
responses of the heart to mechanical stimuli, and they will not be considered in detail here (for a review
on VAC, see30).
SAC were discovered in 1984 in embryonic chick skeletal myocytes by Guharay and Sachs.31 In
subsequent years, SAC have been identified in many other cell types32,33 including cardiomyocytes.34
Cardiac SAC can be either cation non-selective (SACNS)
34 or potassium-selective (SACK)
35 (Figure 3). The
development of the patch clamp technique was vital for the study of cardiac SAC, and it revealed, in
addition to stretch-activated whole-cell currents, evidence of single-channel activity in atrial
myocytes,35 foetal34 and (for SACK at least) adult ventricular myocytes,
36 as well as cardiac
non-myocytes.19 That said, formation of membrane patches is associated with significant alterations in
local mechanical and structural properties, especially in complex and densely ‘crowded’ cells such as
cardiac myocytes. This leaves the potential for false-positive (e.g. channels that would normally be
protected from opening, such as by cytoskeletal interaction) and false-negative observations (channels
that are constitutively activated by patch formation may not be identified as mechano-sensitive upon
additional patch deformation). This highlights the importance of multi-level investigations, combining
a range of electrophysiological recording techniques, from lipid bilayers to sub-cellular and cellular
studies in expression systems and native cells, to cultures, tissue slices, native tissue and organs, right
through to whole animal or patient research. As pointed out elsewhere, much of this hinges on the
availability of improved pharmacological agents, and it requires quantitative structure-based
integration, such as by computational modelling.
First insights into the structure and possible mechanisms of operation of these channels were
provided by the cloning and crystallization of two bacterial SAC.37,38 However, even after an exhaustive
search, no sequence homologues of these particular ion channels were found in mammals. The first
cloned mammalian SAC was the TREK channel (a ‘tandem of two-pore Kþ domains in a weak inwardly
rectifying Kþ channel’ ¼ TWIK-related potassium channel).39 Despite these significant steps, the
molecular identities of mammalian cardiac SAC have yet to be determined.
In spite of a lack of firm molecular identification, there are several prominent candidates for
mammalian cardiac SAC, and these will be reviewed here. For SACNS these include transient receptor
potential (TRP) channels, and Piezo1. SACK candidates are TREK-1, the large-conductance calcium-
activated Kþ channel (BKCa; a member of the ‘Big K
þ’ channel family), and the ATP-sensitive potassium
channel (KATP); see Table 1.
In the following, we evaluate the available evidence for presence and contributions of these main
cardiac SAC candidates, including their sensitivity to pharmacological interventions, highlight some of
the present experimental challenges, and conclude with a consideration of anticipated further
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Figure 2. SAC current recording (top) and patch pipette suction (middle) used for membrane deformation
(bottom). Using the patch clamp technique, the most common way to cause mechanical stimuli is to apply
negative pressure to the inside of the pipette; this induces membrane patch deformation (inserts). At the
beginning of the protocol, after seal formation but in the absence of additional suction, channels are closed
(no current). If negative pressure is applied (first pulse), channels open (here two openings of a single SAC).
After a brief release, a higher level of suction is applied. This increases the open probability of the SAC (second
pulse), but not the single channel conductance (same current amplitude). The original current trace shown here
was taken from a potassium selective SAC; insets adapted from F. Aguila (CNRS), with permission.
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developments in this exciting and dynamic field of translational heart research. We will not discuss
alternative mechano-sensors, detailed signalling pathways, or protein-protein interactions, all of which
form deserving topics for separate reviews.
SACNS
Whole-cell currents with a linear current-voltage relationship attributed to SACNS (ISAC,NS), were first
identified in cardiac cells by Craelius et al.,34 using whole-cell patch clamp recordings from neonatal rat
ventricular myocytes. By applying a voltage clamp, Zeng et al.40 later described the properties of this
current further, including a lack of inactivation and a pronounced sensitivity to block by gadolinium
ions (Gd3þ). The channel’s reversal potential is positive to the resting potential of working
cardiomyocytes, so that activation of SACNS will depolarise resting cells.
27 In contrast to SACK, SACNS
are distinctly sensitive to a peptide, isolated by Sachs et al. from Chilean tarantula venom: GsMTx-4
(Grammostola spatulata Mechano-Toxin 441). The use of GsMTx-4 has allowed researchers to extend
the evidence on whole-cell ISAC,NS towards identification of SACNS effects at the tissue and whole organ
levels. At the same time, no SACNS single-channel recordings from freshly-isolated adult ventricular
cardiomyocytes have been reported. This has led to the suggestion that SACNS may be localised in
membrane regions that are difficult to access in patch clamp studies, such as transverse tubules
(T-tubules42), caveolae (which, themselves, form a mechanosensitive structural domain that may be
integrated into the surface sarcolemma by excess stretch43), or at intercalated discs.44 The main
molecular candidates for cardiac SACNS, TRP channels
45 and the recently discovered Piezo1 protein,46
will be discussed in more detail.
TRP CHANNELS
TRP proteins form a family of widely expressed cation channels, responsible for a variety of cellular
functions. Polymodal regulation is a distinct feature of TRP (http://www.ncbi.nlm.nih.gov/gene/724608).
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Figure 3. Overview of cation non-selective (SACNS) and potassium-selective (SACK) channel function, effects, and
pharmacological modulators. A. SACNS opening leads to sodium and possibly calcium entry (in addition to also
present potassium fluxes); this depolarises the plasma membrane during diastole, repolarises it during early
systole, and may cause after-depolarisation-like behaviour in later stages of action potential repolarisation,
depending on the current’s reversal potential (usually in the mid-region between systolic and diastolic peak
potentials). B. SACK opening leads to potassium exit from the cytoplasm; this acts to hyperpolarize the plasma
membrane during diastole, and to repolarize it during systole. SAC modulators are summarized in boxes, with
the more selective ones at the top of each table. Channels: mKATP: mitochondrial KATP, sarcKATP: sarcolemmal
KATP, Gd
3þ: gadolinium ions, TEA: tetraethylammonium, TNP: trinitrophenol, CPZ: chlorpromazine.
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Known activators of TRP channels include chemical stimuli, temperature elevation, and mechanical
interventions ranging from local patch deformation to membrane stretch and shear strain.47
In particular, the so-called ‘canonical’ TRP channels TRPC1 (http://www.ncbi.nlm.nih.gov/gene/7220)
and TRPC6 (http://www.ncbi.nlm.nih.gov/gene/7225) have been implicated as candidates for
cardiac SACNS.
TRPC1: Analysis of mRNA expression suggested that TRPC1 is present in the human heart.48 Using
immuno-histochemical labelling and confocal imaging, TRPC1 protein was found to colocalise with
phalloidin stain in rat ventricular myocytes.42 This suggests that TRPC1 may be located in T-tubules and
is consistent with the hypothesised spatial distribution of endogenous SACNS in adult ventricular
cardiomyocytes.
Mechanosensitivity of TRPC1 was first noted by Maroto et al.49 in Xenopus oocytes. In their
experiments, ISAC,NS was measured after membrane protein fractionation and reconstitution of
individual proteins in liposomes. A particularly mechanosensitive fraction was found to contain an
80-kDa protein which was immunoreactive to TRPC1 antibody, indicating the presence of a TRPC1
homologue. Further expression of the human TRPC1 (hTRPC1) isoform in Xenopus oocytes and Chinese
hamster ovary (CHO) K1 cells increased ISAC,NS tenfold, whereas microinjection of antisense hTRPC1 RNA
greatly reduced ISAC,NS in both cell types.
Since publication, these findings have been challenged by several studies, including one by some of
the authors of the original report. They found that transfection of hTRPC1 into COS cells (a fibroblast-
related cell line, originally derived from kidney tissue of monkey) had no discernible effect, while
transfection of a different putative SAC (the SACK TREK-1; see below), induced an increase by three
orders of magnitude in mechanosensitive whole-cell currents. This result puts into question the
significance of the less pronounced (ten-fold) increase seen in the earlier experiments.50 The authors of
the later study found limited ion channel expression at the sarcolemma, which is in agreement with a
more recent report showing predominantly intracellular expression of transfected TRPC1 in a skeletal
muscle cell line, unless co-expressed with Cav3 (http://www.ncbi.nlm.nih.gov/gene/859).51 Thus,
even if TRPC1 is successfully transfected, it may require associated molecular machinery for a correct
subcellular localization and/or proper function. In addition, TRPC1 may require other TRPC isoforms to
form a functional heteromeric channel.52
The conflicting results reported above highlight problems that can be associated with the use of
heterologous expression systems to study cardiac ion channels. Clearly, the intracellular environment
of stable cell lines differs significantly from that of cardiomyocytes, while additional transfection with
exogenous ion channels can alter the structure and function of recipient cells.50 Given the dependence
of SAC gating properties on micro-mechanical and structural properties of a cell, it is difficult to
establish suitable control protocols,50 or to arrive at definitive conclusions from these experiments.
Interestingly, mice in whom TRPC1 has been knocked out (TRPC12/2 ) exhibit no significant difference
in ventricular slow force response (SFR, initially characterised in cat papillary muscle,53 is a gradual,
Table 1. Summary of the currently known main molecular candidates for stretch-activated ion
channels in cardiac myocytes. TT: T-tubules, S: sarcolemma; N/S: not specified.
Location
Ion channels Species Cellular Sub-cellular
SACNS
TRPC1 Human48 Myocardium N/S
Rat42 Atrial myocyte S
Ventricular myocyte TT
TRPC6 Human48 Myocardium N/S
Mouse58 Ventricular myocyte TT
TRPV2 Mouse62 Myocardium N/S
TRPV4 Neonatal rat64 Ventricular myocytes Nucleus
TRPM4 Rat158 Myocardium N/S
Piezo1 Rat74 Myocardium N/S
SACK
TREK-1 Rat80 Atrial myocyte S
Ventricular myocyte N/S
BKca Chick embryo
94,129 Ventricular myocyte S
KATP Neonatal rat
159 Atrial myocyte S
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calcium-related increase in muscle contractility upon exposure to maintained stretch), compared to
wild-type controls.54 This suggests that TRPC1 may not be an obligatory and/or exclusive component of
the SFR (similar findings were reported for TRPC3 (http://www.ncbi.nlm.nih.gov/gene/7222)55).
However, as with all knockout experiments, there is always the possibility of compensatory changes in
expression of other genes. One way of assessing this would be to use acute knockdown experiments,
ideally involving tissue-specific drivers of protein expression. It would also be instructive to explore
acute MEF responses that would be expected to precede the SFR in cardiac myocytes or tissue
preparations of TRPC12/2 mice.
TRPC6: Mammalian TRPC6 was initially identified as a mechanosensitive ion channel by Spassova
et al.,56 who found that overexpression of TRPC6 in human embryonic kidney cell line 293 (HEK293)
cells induced ISAC,NS. However, a subsequent study by Gottlieb et al.
50 found that TRPC6 overexpression
in CHO and COS cells had no significant effect. More recently, it has been suggested that TRPC6 is not
mechanosensitive, unless co-expressed with the angiotensin II type 1 (AT1) receptor.45,47 Data, more
directly relevant for cardiac mechanosensitivity, came from Dyachenko et al.,58 who used mouse
ventricular myocytes, as opposed to heterologous expression systems. Their whole-cell patch clamp
experiments identified a robust ISAC,NS in response to shear stimuli, which was inhibited by
pore-blocking TRPC6 antibodies. TRPC6 knockout blunts the SFR in wild-type murine models, while its
genetic down-regulation or pharmacological block returns ‘hyper-responsive’ murine models of
Duchenne muscular dystrophy back to normal SFR levels,55 highlighting the potential clinical relevance
of targeted TRPC6 manipulation.
TRPC6 is among a small number of SAC candidates that is highly expressed in human heart
homogenates.48 In murine heart, TRPC6 appears to be localised to T-tubules.58 In agreement with this
observation, detubulation inhibits ISAC,NS in murine cardiomyocytes.
58 Interestingly, a recent paper has
suggested that the localization of TRPC6 shows marked plasticity in response to sympathetic
stimulation via a1A receptors, and that these channels can translocate from T-tubules to the
sarcolemma.59 Whether this occurs physiologically is unclear; however, pre-treatment with
a1A-agonists might serve as a useful experimental intervention to facilitate single-channel recordings
of TRPC6, and potentially other channels localised in T-tubules, in adult ventricular myocytes.
Other TRP channels: Several other members of the TRP family are mechanosensitive and are
expressed in the heart. The TRPC3 protein has been identified in rat ventricular myocytes, also located
in T-tubules.60 Mechanical stretch of neonatal cardiomyocytes in a mouse model displays TRPC3
overexpression induced ROS production, similar to TRPC3-activation by 1-oleoyl-2-acetyl-sn-glycerol
(OAG). However, OAG is a fairly unspecific activator of TRPC channels, so effects cannot be attributed
with confidence to TRPC3.60 The vanilloid TRP channel 2 (TRPV2 (http://www.ncbi.nlm.nih.gov/gene/
51393)) has been reported to be mechanosensitive (studied using cell-volume changes and patch
pipette suction61) and is expressed in the mouse heart.44,62 Using the TRPV2 agonist probenicid
in wild-type and TRPV22/2 constitutive knockout mice, it was shown that this channel appears
to contribute to baseline cardiac function, participating in the calcium-handling machinery of
heart cells.62
TRPV4 (http://www.ncbi.nlm.nih.gov/gene/59341) mRNA is weakly expressed in cardiac muscle,63
and TRPV4 protein was located in cultured neonatal rat ventricular myocytes only in the nucleus.64
However, caution is warranted here, regarding mRNA or protein expression in tissue. Firstly, mRNA and
protein expression levels do not necessarily correlate65 and secondly, while high expression levels are
confirmatory of a significant presence and indicative of functional relevance, low expression in whole
tissue homogenates should be interpreted with care. If a protein is present in minority cell populations
of the heart (such as Purkinje fibres), it could be of immense functional relevance, even if it was only
detected at trace levels. In addition, some SAC, such as TREK, may be expressed at the membrane, but
can be strongly inhibited in resting conditions,66 making the assessment of availability of functional
channels even more difficult.
Finally, the melastatin TRP channel 4 (TRPM4) is expressed in cardiomyocytes,45 and has been
implicated in stretch-activated responses of vasculature smooth muscle cells.67 Overexpression of
TRPM4 may be involved in an inheritable form of progressive familial heart block type I,68 and the
identification of a possible stretch-activated component of this disease – mediated by TRPM4 – would
be of pronounced clinical relevance. Thus, in addition to TRPC1 and TRPC6, the ion channels TRPC3,
TRPV2, TRPV4 and TRPM4 form translationally-relevant targets for further basic and applied research.
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Piezo1
The discovery of Piezo1 and Piezo2 (http://www.ncbi.nlm.nih.gov/gene/63895) by Patapoutian’s group
in 201046 represents one of the most important breakthroughs in the field of mechanotransduction in
recent years. Piezo1 was initially identified in the neuro-2a neuronal cell line by siRNA knockdown of
the expression of membrane proteins with unknown function. Knockdown of the FAM38A (http://www.
ncbi.nlm.nih.gov/gene/415849) gene inhibited ISAC,NS and the gene product was named Piezo1.
Mechanosensitivity was confirmed by heterologous expression of Piezo1 in HEK cells, which induced
a robust ISAC,NS. Piezo1 is huge, containing approximately 2,500 amino acids, arranged in 24–32
transmembrane domains that assemble as a tetramer.69 Intuitively, this massive structure, and the
associated large surface area, could be well-adapted for sensing changes in bilayer curvature and/or
stretch. In line with this hypothesis, it has been shown that Piezo1 gating is associated with
dimensional changes.70
Currently, no data has been published directly addressing Piezo1 mechanosensitivity in the heart.
However, Piezo1 channel electrophysiological properties are similar to that of endogenous cardiac
SACNS, including weak voltage dependency, comparable single channel conductance, inactivation,
and sensitivity to GsMTx-4.71–73 Furthermore, Piezo1 mRNA is expressed in the murine heart46,74
albeit at low levels (see comment on whole-tissue expression levels, above). Piezo1 is involved in
erythrocyte volume homeostasis. Morpholino-mediated knockdown of Piezo1 results in swelling
and lysis of red blood cells and consequent anemia.75 Interestingly, this function is close to that
of bacterial mechanosensitive channels of large and small conductance (MscL and MscS).76
Undoubtedly this is an exciting and dynamic area of development. Basic science questions
concerning structure, protein partners, and regulation of Piezo1 need to be addressed,77 as does
the question of whether Piezo1 is present in, and relevant for, the human heart.
SACK
Whole-cell SACK currents (ISAC,K) were first described by Kim et al.
35 in rat atrial myocytes. In contrast
to SACNS, SACK, are outwardly rectifying, and as such, allow potassium ions to move more easily out
of the cell than into it. Compared to SACNS, SACK tend to have larger single channel conductances.
They also inactivate in a time-dependent manner and are generally insensitive to GsMTx-4.78 Being
potassium-selective, their reversal potential lies negative to the resting membrane potential of cardiac
cells, so activation of SACK will generally cause membrane repolarisation or hyperpolarisation.
27
To date, single-channel recordings of ISAC,K in adult mammalian cardiac myocytes have been obtained
from atrial35 and ventricular myocytes,36,79,80 suggesting that their subcellular compartmentalization
differs from SACNS. Primary molecular candidates for cardiac SACK are TREK-1, BKCa and KATP.
TREK-1
TREK-1 is a member of the two-pore domain potassium channel family, which is associated with a ‘leak’
potassium ion conductance in cardiomyocytes.81 TREK-1, however, displays more complex permeation
and gating properties than a simple ‘leak’ channel, and is regulated by a number of factors including
pH, temperature, second messenger systems, and membrane deformation/stretch.82 Mechanosensi-
tivity was attributed to TREK-1 by Patel et al.39 based on single-channel patch clamp recordings from
transfected COS cells. Subsequently, Terrenoire et al.83 demonstrated that ISAC,K (endogenous to rat
atrial myocytes) displays a number of properties that bear striking similarities to recombinant TREK-1
channels. This includes their single-channel conductance, lack of voltage dependency, ‘burst mode’
activity, and sensitivity to pharmacological interventions, and, in particular, a unique sensitivity to
volatile anaesthetics not shared by other cardiac potassium ion channels.81
A number of studies have identified TREK-1 mRNA expression in rat atria, as well as in left, right, and
septal ventricular myocytes.83–86 The protein appears to be arranged in longitudinal stripes at the
surface of cardiomyocytes: a pattern that might support directional stretch sensing.80 At the tissue
level, TREK-1 expression is distinctly heterogeneous, with a gradient of mRNA expression that
increases, transmurally, from epicardial to endocardial cells.86 This heterogeneity appears to correlate
with transmural changes in MEF sensitivity, where stretch causes the most pronounced action potential
shortening in the sub-endocardium.87 To our knowledge, mRNA analysis thus far has failed to identify
TREK-1 expression in the human heart.88,89 It has been suggested that the TWIK-related arachidonic
acid-activated potassium channel (TRAAK (http://www.ncbi.nlm.nih.gov/gene/50801)) or TWIK-related
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acid-sensitive potassium channel (TASK-1 (http://www.ncbi.nlm.nih.gov/gene/3777)) of the K2P family,
which appear to be expressed in the human heart,90 may act as TREK-1 homologues. Indeed, when
TRAAK is expressed in heterologous model systems, it forms a channel with very similar properties to
TREK-1.91 Characterisation of both the presence and functional relevance of these ion channels in
human requires further elucidation.
BKCa
BKCa channels have large conductances, and they respond to voltage changes and alterations in
intracellular calcium ion concentration in a manner that allows them to contribute to repolarisation.92
Functionally, BKCa channels have been suggested to control heart rate and to offer cardioprotection
during ischaemia.93 Kawakubo et al.94 identified mechanosensitivity of BKCa channels in membrane
patches excised from cultured embryonic chick ventricular myocytes. Attempts to measure
single-channel activity in post-hatch chick cardiomyocytes have been unsuccessful, although Iribe
et al.95 characterised a whole-cell ISAC,K which was sensitive to iberiotoxin (a BKCa inhibitor).
Interestingly, this ISAC,K was also sensitive to extracellular sodium. The authors suggest that BKCa
activation could occur secondary to mechanical modulation of sodium ion influx (e.g. via SACNS), and
consequentially shift sodium-calcium exchanger activity towards preservation of intracellular calcium.
If this is the case, BKCa might not be directly stretch sensitive.
Whether or not BKCa channels are responsible for ISAC,K in embryonic chick cardiomyocytes, there is
little evidence to suggest that BKCa channels form cardiac SACK in other species. In the human heart,
BKCa channels are sparsely expressed,
92 and they may be confined to cardiac fibroblasts (where BKCa
was detected using Western blot96). However, functional fibroblast-myocyte electrical coupling can
occur (at least in some areas of the heart97,98) so it is possible that stretch-activation of BKCa channels
in cardiac fibroblasts could still affect myocyte function via a heterocellular coupling pathway.
KATP
Although classically considered to be ligand-gated, Van Wagoner et al.99 obtained single-channel
inside-out patch clamp recordings from neonatal rat atrial myocytes which revealed that patch pipette
negative pressure increased KATP channel ATP-sensitivity.
99 Synergistically, ATP-reduction potentiated
stretch sensitivity.99 Ischaemia, simulated in adult guinea pig ventricular myocytes by application of a
metabolic uncoupler, also uncovered KATP mechanosensitivity that was absent in control conditions,
27
an observation that was more recently confirmed in rat cardiomyocytes.100 The synergism for KATP
channel activation bymetabolic andmechanical stress might explain differences in quantitative aspects
of ATP reduction needed to activate KATP in isolated cells, compared to the organ level (where KATP open
at less depleted ATP levels). A reason for this difference could be the fact that isolated cells are not
normally subjected to mechanical co-activation, while at the organ level ischaemia is usually associated
with decreased shortening, or even stretch, of the tissue affected by reduced availability of ATP.
In keeping with this notion, ‘stretch-preconditioning’ has been reported to reduce ischaemia-
reperfusion injury, an effect that disappears when KATP channels are blocked.
68 Moreover, cardiac
fibroblasts progressively express functional KATP channels in scar and border zone tissue following
infarction, suggesting that we must consider the effect of cells other than cardiomyocytes in pre-/post-
conditioning of the heart, and the role of SAC in these processes.101– 103
Although there is little evidence to suggest that KATP are responsible for mechanosensitivity of the
heart in normal beat-by-beat physiology (in healthy cells and tissue, diastolic mechanical stimulation
depolarizes cardiomyocytes), the potential role of these ion channels in ischaemic or other disease
conditions warrants further research.
SAC MODULATORS
Several pharmacological compounds have been identified to modulate SAC activity (Figure 3),104,105
and their potential role as pharmacological tools for heart rhythm management has been previously
reviewed by White.106
Most of the known SAC-modulators are non-specific inhibitors, such as gadolinium ions, amiloride
and cationic antibiotics (streptomycin, penicillin, kanamycin). Among the very few specific SAC
inhibitors107 reported so far is the peptide GsMTx-4. It inhibits TRPC5 when activated by hypo-osmotic
and receptor stimulation,108,109 as well as TRPC6,56 and Piezo1 channels when applied to the external
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face of the membrane.72,73 GsMTx-4 is active both in its D and L enantiomers, showing the mechanism
of action is not stereospecfic or chiral.110 Instead, the mode of action of GsMTx-4 is thought to involve
insertion into the outer membrane leaflet in the proximity of the channel, relieving lipid stress and
favouring the closed state of SAC.110 Counterintuitively, GsMTx-4 sensitizes the bacterial channels,
MscS and MscL, to tension,111 while it has no effect on TREK-1 channels,72 so that overall the mode of
action of GsMTx-4 still requires further elucidation.
TREK-1 is poorly responsive to classic potassium channel blockers,112 but its functions are modified
by a variety of pharmacologic agents such as volatile anaesthetics,112 riluzole,113 fluoxetine114 and
spadin.115,116 Recently, new modulators of TREK-1 were identified by Bagriantsev et al.117 They
characterized inhibitors and, importantly, activators (which are very rare for SAC channels). Known
openers for SAC are amphipathic substances which insert selectively into one membrane leaflet only,
locally inducing either concave or convex curvature, which may induce SAC-activating tension.118
Other useful substances include probenicid, which is a TRP agonist that is fairly specific to TRPV2,119
and 9-phenanthrol, which blocks TRPM4.120
It is important to note, though, that not all SAC blockers that work at the level of isolated or cultured
cells are equally efficient in native tissue. Streptomycin, for example, may not be able to easily access
SAC in whole cardiac tissue,121 even though it is an efficient SACNS blocker in single cardiomyocytes (an
important consideration for cell-culture based work, which often employs media containing
streptomycin by default). This will be one of the reasons for which antibiotics, such as streptomycin,
can be prescribed to patients without instantaneous side effects on stretch-sensing. Another
compound, Gd3þ, is used clinically in a chelated formulation, which explains the lack of pronounced
immediate SAC-effects in radio-contrast studies. As an aside, Gd3þ precipitates in physiologically
buffered solutions.122 Clearly caution is called for when assessing (potentially false-) negative results
on Gd3þ effects in physiological solutions, or on streptomycin effects in vivo.
DISCUSSION
The heart is a superbly mechanosensitive organ. SAC are thought to provide one of the mechanisms
underlying cardiac MEF,20,123,124 the process by which changes in the mechanical environment of the
heart lead to altered cardiac electrical activity. Identification of molecular substrates for cardiac SAC will
not only provide novel insight into processes that underlie MEF, but also support the long-term aim of
developing SAC-specific drugs for the treatment of mechanically induced cardiac pathologies.106
In terms of physiological beat-by-beat effects, activation of SAC has been shown to underlie the
stretch-induced increase in spontaneous sino-atrial node (SAN) cell pacemaking rate.16 Block of SAC
using GsMTx-4 terminates this positive chronotropic response in SAN tissue121 which, in its guise of a
respiratory sinus arrhythmia, persists at whole body level – even in heart transplant recipients after
additional pharmacological denervation.125
At the same time, sustained pressure and/or volume overload favour arrhythmogenesis.25,124,126,127
Application of SAC-blockers such as GsMTx-4 has been shown to reversibly reduce the preload
dependent increase in both incidence and duration of burst-pacing induced atrial fibrillation in isolated
heart experiments.28 In patients, it can be difficult to distinguish stretch-induced changes in
electrophysiology from other chronically occurring aspects of structural and functional remodelling.
However, an impressive illustration of acute effects of ventricular loading has been provided by
Waxman et al.,128 who showed that performing the Valsalva manoeuvre may terminate ventricular
tachycardia by temporary reduction of ventricular filling. The Valsalva manoeuvre, an attempt to
forcefully exhale against the closed glottis, increases intrathoracic pressure, favouring a net reduction
of intravascular volume in the chest (i.e. impeding venous return and favouring arterial drainage to
other parts of the body). In this study, the reduction in cardiac dimensions was confirmed
radiographically. Cessation of ventricular tachycardia coincided with removal of ventricular strain, while
arrhythmia resumption occurred upon refilling after the end of the manoeuvre. Since this type of
response can be seen not only in neurologically intact, but also in pharmacologically128 or surgically7
denervated patients (transplant recipients), it is not attributable to a nervous reflex. This highlights how
removal of strain may unmask the presence of stretch-induced arrhythmias, even in a chronic setting.
Various SAC have been implicated in the heart’s (patho-)physiological responses to mechanical
stimuli, but in the absence of firm identification of molecular substrates for cardiac SAC, successful
mechanistic exploration of cardiac mechanosensitivity is a challenging task.
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Conceptually, it is pragmatic to subdivide SAC into two categories, SACNS and SACK. For both, there
are several candidate proteins. SACNS were initially thought to be formed by TRP proteins and, most
convincingly, TRPC6 antibodies inhibit whole-cell ISAC,NS in mouse ventricular myocytes.
58 However,
subsequent heterologous expression studies yielded conflicting results.50,56 More recently, attention
has turned towards the newly discovered Piezo1 channels.46 Although there is no published data yet
on specific electrophysiological effects of Piezo1 in cardiomyocytes, comparative kinetic analysis
suggests that these proteins may function as cardiac SACNS. In as far as cardiac SACK are concerned,
recombinant TREK-1 has remarkably similar properties to endogenous SACK,
78 but the protein has
yet to be identified in human heart.88 BKCa channels have also received considerable interest, but their
stretch-sensitivity, if present,95 may be limited to immature129 and/or non-mammalian
cardiomyocytes,94 or to cardiac connective tissue.96 Finally, KATP channels display metabolic and
mechanical co-activation,99 which may help explain some of the differences between experimental and
clinical findings on the extent of ATP-reduction needed to activate them. In addition, this insight could
shed light on hitherto ill-explored links between ischaemic and mechanical preconditioning.
As will be apparent from the above, the currently available information on the molecular substrates
of cardiac SAC poses more questions than it answers. A number of reasons contribute to this. It is
notoriously difficult to control and/or quantify the extent and quality of local mechanical stimuli that an
individual ion channel is exposed to.130 Tools to apply strain at whole-cell, tissue, and organ levels
exist (including the application of shear stress, axial stretch, or cell volume changes), but there is no
commonly implemented ‘gold standard’ for the stimulation of SAC.27 Furthermore, these techniques
have been used with a wide variety of cellular models from different species and developmental
stages, making cross comparison of results challenging. In addition, it is difficult to interrelate
macroscopic interventions and observations at cell and tissue levels with molecular substrates: in part
because there is no ‘zero-strain’ reference even in patch clamp studies. Attempts to explore causal
links from low-level mechanism to integrated response, and back, include changes in gene
expression,87 pharmacological interventions,131 and computational modelling.132– 135
Further challenges arise from the possibility that ventricular SAC may be localised in T-tubules,
caveolae, or intercalated discs. This is thought to explain why patch clamping of single SAC is so
rare in freshly isolated ventricular cardiomyocytes from adult mammals.130 One possible way around
this problem may be to use pre-exposure to a1A receptor stimulation, to aid SAC translocation
from T-tubules to the sarcolemma.59 Another would be pre-stretching of the cardiac tissue prior to
cell isolation, as this can cause surface membrane incorporation of caveolae.43 Thirdly, one could
isolate the T-tubules using sequential centrifugation of homogenised cardiomyocytes followed by
purification of T-tubule membranes by vesicle immuno-isolation and reconstitution into a continuous
membrane.136 It might then be possible to directly patch clamp SAC on the isolated T-tubule
membrane. Less invasively, scanning ion conductance microscopy, which generates a three-dimen-
sional topographical map of the cell surface prior to patch clamping, has been suggested as a means to
directly target the T-tubule ostium where SAC are more likely to be present.137 On the other hand, there
is evidence to suggest that SAC may activate indirectly via second messenger signalling cascades.138
Therefore patch clamping single ion channels (where SAC activation probably occurs as a direct
result of bilayer deformation130) may provide only a partial picture of patho-physiological function.
In addition to SAC in the outer cell membrane, there may be non-sarcolemmal SAC in the
sarcoplasmic reticulum12 or mitochondria.139,140 Cardiac non-myocytes are also mechanosensitive and
exhibit electrophysiological properties modulated by mechanical stimuli.18,141– 143 Channels, such as
Nav1.5 and TRPM7, that were initially identified as stretch-modulated in non-cardiac cell types,144,145
have now been found in cardiac fibroblasts.146,147
Finally, there is a growing body of evidence to suggest that many cardiac ion channels, even those
that are not classically considered as SAC (e.g. voltage- or ligand-gated channels), are sensitive to
mechanical modulation of their gating behaviour.148 Future research should therefore focus on
characterising the mechanical stimuli experienced by cardiomyocytes in vivo, so that they can be more
closely replicated in vitro. This can be aided greatly by high-resolution imaging of the beating heart,149
followed by whole heart histological reconstruction150,151 and subsequent computational re-integration
of tissue deformation152,153 with a granularity that allows identification of local stress-strain
dynamics154 and prediction of microstructural effects on electrophysiology.155 Direct measurement, and
validation of modelling predictions, currently suffers from a number of technical limitations, in
particular the inability to measure locally acting forces in situ. The recent development of Fo¨rster
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Resonance Energy Transfer (FRET)-based force sensors that can be genetically inserted into
intracellular proteins,156 may open up a treasure chest of novel insight if they can be applied to heart
research. These force sensors are based on the energy transfer between two compatible fluorophores.
The efficacy of the energy transfer is inversely proportional to the distance between the donor and the
acceptor, multiplied by 106, making the FRET signal very sensitive to small distance changes. Meng
and Sachs157 have calibrated their probe using DNA to be able to quantify forces from fluorescent
signal changes. These sensors constitute a very powerful tool for the assessment of the mechanical
state in components of single cells or tissues. Until now little is known about forces within the
cell/cytoskeleton, both when cells are at rest, or while mechanically stimulated. In addition,
intracellular force reporters would be very useful to improve our understanding of the interplay of SAC
with other mechanosensors, like integrins and the cytoskeleton.
Armed with a more thorough understanding of physiological mechanical stimuli, and novel
techniques, we expect to improve our understanding of the molecular substrate of cardiac SAC, and to
better predict their pathophysiological roles for the regulation of heart rate and rhythm in the
mechanosensitive heart (Figure 4).
CONCLUSION
The heart is an integrated electro-mechanical system (Figure 1). SAC (Figure 2) are key contributors to
cardiac mechanosensitivity. SACK generally cause re- (or even hyper-) polarisation, while SACNS
depolarise resting tissue and have differential effects on activated cells (speeding up early, delaying
late, repolarisation; Figure 3). Systemic effects of SAC activation therefore depend on timing (relative to
the cardiac cycle), intensity (e.g. relative to excitation threshold), and location (relative to the different
components of cardiac tissue; Figure 4). Thus, diastolic stretch may accelerate heart rate, or even
trigger extra beats, depending on whether pacemaker cells or working myocardium drive the response.
This is believed to underlie mechanical pacing by pre-cordial percussion, and the occasionally
observed termination of re-entrant arrhythmias upon application of pre-cordial thump.160–162 Systolic
stretch will alter repolarisation dynamics which, in particular in the context of spatially heterogeneous
mechanical stimuli and/or regionally varying expression of SAC, may act as an arrhythmia-sustaining
mechanism for mechanically-induced rhythm disturbances.
We are on the brink of obtaining an improved understanding of the molecular substrates of cardiac
SAC, and of the way in which macroscopic mechanical interventions translate into stimuli at subcellular
levels. This is hoped to lead to improved insight into the physiological relevance of SAC, their
involvement in acute and chronic diseases, and to guide the development of novel means to targeting
cardiac SAC for therapeutic benefit.
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Figure 4. Timing-, amplitude-, and target-dependent stretch effects on heart rhythm. AP: action potential,
D: change in. Adapted from Kohl et al., 1998, with permission.
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LIST OF ABBREVIATIONS
BKCa: Large-conductance calcium-activated potassium channel
CHO: Chinese hamster ovary cell line
GsMTx-4: Grammostola spatulata Mechano-Toxin 4
HEK: Human embryonic kidney cell line
ISAC,K: Potassium-selective stretch-activated current
ISAC,NS: Cation non-selective stretch-activated current
KATP: ATP-sensitive potassium channel
MEF: Mechano-electric feedback
MSC: Mechanosensitive ion channels
OAG: 1-oleoyl-2-acetyl-sn-glycerol
SAC: Stretch-activated channels
SACK: Potassium-selective SAC
SACNS: Cation non-selective SAC
SFR: Slow force response
TASK: TWIK-related acid-sensitive potassium channel
TRAAK: TWIK-related arachidonic acid-activated potassium channel
TREK: TWIK-related potassium channel
TRP: Transient receptor potential
TRPC: Canonical TRP channel
TRPM: Melastatin TRP channel
TRPV: Vanilloid TRP channel
TWIK: Tandem of two-pore Kþ domains in a weak inwardly rectifying Kþ channel
VAC: Volume-activated ion channels
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